New infusion aims to keep severe heart failure patients out of hospital
Disease control
Not yet recruiting
This study tests a continuous 6-month infusion of alprostadil (ALP-1) in 600 adults with advanced heart failure and reduced pumping ability. The goal is to see if it delays death, need for a heart transplant, or worsening heart failure compared to a placebo. Participants must hav…
Phase: PHASE3 • Sponsor: Biopeutics Co., Ltd • Aim: Disease control
Last updated May 17, 2026 11:32 UTC